Hydroxypropyl Methylcellulose Capsules Market Size was valued at USD 0.384 Billion in 2022. The Hydroxypropyl methylcellulose capsules industry is projected to grow from USD 0.420 Billion in 2023 to USD 0.861 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.40% during the forecast period (2023 - 2032). Rapid expansion of pharmaceutical sector the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Hydroxypropyl methylcellulose (HPMC) capsules is the expanding pharmaceutical industry. This rise is the result of a number of important reasons that demonstrate the critical place HPMC capsules play in the field of medication delivery. HPMC capsules are extremely adaptable and can be tailored to fit particular needs in medication development. They come in a variety of sizes and are simple to fill with varied API dosages, providing dosing versatility. Additionally, a variety of color and printing possibilities are available to pharmaceutical companies, enabling efficient branding and product distinction. This adaptability is especially useful in the cutthroat pharmaceutical industry, where consumer perception is greatly influenced by product look and branding.
Compliance and regulatory approval are other important factors. The use of HPMC capsules for pharmaceutical purposes has received approval from regulatory agencies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). For pharmaceutical businesses, this regulatory approval streamlines the procedure for approving new medicine formulations, saving time and costs. Additionally, HPMC capsules are in line with the expanding market for clean label goods and drugs suitable for vegetarians or vegans, which is crucial for pharmaceutical businesses looking to meet the different needs of their customers.
Due to its outstanding performance qualities, HPMC capsules are also advantageous to the pharmaceutical business. Because of its higher stability, HPMC capsules shield the medicine they contain from contaminants like air and moisture. For pharmaceutical companies, having a longer shelf life is essential because it guarantees that medicines will continue to be effective and secure for patients for a long time. Furthermore, HPMC capsules have good dissolving characteristics that can increase the bioavailability of some medications and result in more successful treatment outcomes. Thus, driving the Hydroxypropyl methylcellulose capsules market revenue.
The hydroxypropyl methylcellulose capsules market segmentation, based on product, includes with gelling aid and without gelling aid. The without gelling aid segment dominated the market in 2022. Individuals with particular dietary limitations or allergies, such as gelatin allergies, can take HPMC capsules without the use of gelling agents. They are a preferable option for people with dietary sensitivities because they are plant-based, include no components produced from animals, and don't contain any common allergens.
Figure 1: Hydroxypropyl Methylcellulose Capsules Market, by Product, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The hydroxypropyl methylcellulose capsules market segmentation, based on end user, includes pharmaceutical companies, CMO's (contract manufacturing organizations), food and beverage companies and cosmetic companies. The pharmaceutical companies category generated the most income in 2022. For pharmaceutical purposes, HPMC capsules have received approval from regulatory agencies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Pharmaceutical businesses place a high priority on regulatory compliance to guarantee the security and effectiveness of their goods. The acceptance of HPMC capsules by these organizations streamlines the approval procedure for new medicine formulations and provides some guarantee of the security of the final product.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Hydroxypropyl Methylcellulose Capsules Market dominated this market in 2022 (45.80%). North America, and the United States in particular, are renowned for having strict regulatory requirements that are upheld by the U.S. FDA. The requirement to adhere to these stringent rules is what is driving the demand for HPMC capsules in this area. HPMC capsules are a popular option for pharmaceutical businesses wishing to enter or grow in the North American market because they are well-received by the FDA. Further, the U.S. Hydroxypropyl methylcellulose capsules market held the largest market share, and the Canada Hydroxypropyl methylcellulose capsules market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Hydroxypropyl methylcellulose capsules market accounts for the second-largest market share. The European Medicines Agency (EMA) oversees a uniform regulatory system for pharmaceutical products in Europe. Because HPMC capsules are consistent with European standards, pharmaceutical businesses with operations across various European nations find them to be a desirable option. The widespread use of HPMC capsules in Europe is facilitated by the simplicity of gaining approvals. Further, the German Hydroxypropyl methylcellulose capsules market held the largest market share, and the UK Hydroxypropyl methylcellulose capsules market was the fastest growing market in the European region.
The Asia-Pacific Hydroxypropyl Methylcellulose Capsules Market is expected to grow at the fastest CAGR from 2023 to 2032. Traditional medicine and herbal treatments are widely used in healthcare across many Asian nations. To meet the need for natural and holistic healthcare solutions, herbal extracts and conventional treatments are encapsulated in HPMC capsules. Moreover, China’s Hydroxypropyl methylcellulose capsules market held the largest market share, and the Indian Hydroxypropyl methylcellulose capsules market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Hydroxypropyl methylcellulose capsules market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Hydroxypropyl methylcellulose capsules industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Hydroxypropyl methylcellulose capsules industry to benefit clients and increase the market sector. In recent years, the Hydroxypropyl methylcellulose capsules industry has offered some of the most significant advantages to medicine. Major players in the Hydroxypropyl methylcellulose capsules market, including ACG Worldwide Pvt., Ltd., BioCaps Enterprise, Bright Caps GmbH, Bright Pharmacaps Inc., Capscanada Corporation, Capsugel, Inc., Excellent Health Products Co., Ltd., Farmacapsulas S.A., Healthcaps India Limited, Natural Capsules Ltd., Qualicaps, Inc., Shanghai Honest Chem Co., Ltd., Shaoxing Kangke Capsule Co., Ltd., Suheung Co Ltd., Sunil Healthcare, Wuhan Carma Technology Co., Ltd, Zhejiang Yuexi Capsule Co., Ltd. and others, are attempting to increase market demand by investing in research and development operations.
NCL, headquartered in Bangalore, primarily manufactures Empty Hard Gelatin Capsule (EHGC) shells and Empty Hard Cellulose Capsule (EHCC) shells. The company has one manufacturing unit in Bangalore and another in Pondicherry with an aggregate capacity of 7.2 billion capsule shells per annum and caters to both domestic and international markets. NCL's product mix comprises various capsule shells such as Hard Gelatin Capsule Shells, Hard Cellulose Capsule Shells, BSE/TSE Free Gelatin Capsule Shells, Shiny Gelatin Capsule Shells, SLS free Gelatin Capsule Shells, Halal Certified Gelatin Capsule Shells, Fortified Gelatin Capsule Shells, Sweet Gelatin Capsule Shells and Fast Release Gelatin Capsule Shells, among others. Going forward, it plans to set up a third manufacturing unit and diversify into API manufacturing.
Shanghai Honest Chem Co., Ltd., which was established in 2002 and operates under the motto "Faith to success," has since provided both domestic and international customers with high-quality products and attentive service. Shanghai are professional of producing cellulose products, such as Hydroxypropyl Methyl Cellulose (HPMC), Methyl Cellulose (MC), Hydroxyethylmethyl Cellulost (HEMC), Polyvinyl Alcohol Hydroxyethyl Cellulose (HEC), Carboxy methylcellulose Sodium（CMC）,Ethyl Cellulose (EC),Re-dispersible Emulsion Powder (RDP), Polyanionic Cellulose (PAC), Polyanionic Cellulose (PAC). It is heavily utilized by the building, industrial, painting, food, ceramic, and other industries.
ACG Worldwide Pvt., Ltd.
BioCaps Enterprise
Bright Caps GmbH
Capsugel, Inc.
Excellent Health Products Co., Ltd.
Farmacapsulas S.A.
Healthcaps India Limited
Natural Capsules Ltd.
Qualicaps, Inc.
Shanghai Honest Chem Co., Ltd.
Shaoxing Kangke Capsule Co., Ltd.
Suheung Co Ltd.
Sunil Healthcare
Wuhan Carma Technology Co., Ltd
Zhejiang Yuexi Capsule Co., Ltd.
July 2021: The performance materials and coatings businesses, which are expanding quickly, as well as other high-growth end markets, have prompted Dow Chemical Company to launch a series of incremental, high-return capacity increases.
With Gelling Aid
Without Gelling Aid
Pharmaceutical Companies
CMO's (Contract Manufacturing Organizations)
Food and Beverage Companies
Cosmetic Companies
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.384 Billion |
| Market Size 2023 | USD 0.420 Billion |
| Market Size 2032 | USD 0.861 Billion |
| Compound Annual Growth Rate (CAGR) | 9.40% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | ACG Worldwide Pvt., Ltd., BioCaps Enterprise, Bright Caps GmbH, Bright Pharmacaps Inc., Capscanada Corporation, Capsugel, Inc., Excellent Health Products Co., Ltd., Farmacapsulas S.A., Healthcaps India Limited, Natural Capsules Ltd., Qualicaps, Inc., Shanghai Honest Chem Co., Ltd., Shaoxing Kangke Capsule Co., Ltd., Suheung Co Ltd., Sunil Healthcare, Wuhan Carma Technology Co., Ltd, Zhejiang Yuexi Capsule Co., Ltd. |
| Key Market Opportunities | Shift toward Clean Label Products. |
| Key Market Dynamics | Research and Development. |
Hydroxypropyl Methylcellulose Capsules Market Highlights:
Frequently Asked Questions (FAQ) :
The Hydroxypropyl methylcellulose capsules market size was valued at USD 0.384 Billion in 2022
The market is projected to grow at a CAGR of 9.40% during the forecast period, 2023-2032
North America had the largest share in the market
The key players in the market are ACG Worldwide Pvt., Ltd., BioCaps Enterprise, Bright Caps GmbH, Bright Pharmacaps Inc., Capscanada Corporation, Capsugel, Inc., Excellent Health Products Co., Ltd., Farmacapsulas S.A., Healthcaps India Limited, Natural Capsules Ltd., Qualicaps, Inc., Shanghai Honest Chem Co., Ltd., Shaoxing Kangke Capsule Co., Ltd., Suheung Co Ltd., Sunil Healthcare, Wuhan Carma Technology Co., Ltd, Zhejiang Yuexi Capsule Co., Ltd
The Without Gelling Aid category dominated the market in 2022
The Pharmaceutical Companies had the largest share in the market.
Team Lead - Research Anshula mandaokar holds an academic degree in chemical engineering and has been contributing to the field for more than 5 years. she has expertise in market research and business consulting and serves as a team lead for a reputed market research firm under the chemicals and materials domain spectrum. she has worked on multiple projects, generating explicit results in a quick turnaround time. her understanding of data interpretation justifies her role as a leader.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
